Literature DB >> 21619948

Genetic background of multiple sclerosis.

A Dessa Sadovnick1.   

Abstract

Multiple sclerosis (MS) is a one of the group of diseases labeled as "common complex". Virtually all common complex traits, genetic and environmental components have important roles, both independently and interactively, in disease susceptibility and stochastic and epigenetic effects cannot be overlooked. Data presented are largely part of the Canada-wide prospective, population-based longitudinal Canadian Collaborative Project on Genetic Susceptibility to MS (CCPGSMS) which includes over 30,000 unique families having at least 1 member with MS. Findings do not support a general propensity to autoimmune disease in MS families, but clearly highlight the importance of controlling for gender (patient, informant) when conducting such studies. The MHC class II association has been fine-mapped to the HLA-DRB5*0101-HLA-DRB1*1501-HLA-DQA1*0102-HLA-DQB1*0602 extended haplotype. This HLA haplotype confers a relative risk of approximately 3 and homozygosity for this haplotype increases the risk by over 6 fold. However, the HLA haplotype loci interactions are complex and include, epistasis, trans and cis effects, and parent-of-origin effects. As well, there may be interactions of EBV and vitamin D with the HLA, In conclusion, using MS as an example, susceptibility for common complex disease most likely results from interactions of genes, environmental interactions and gene/environment interactions.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619948     DOI: 10.1016/j.autrev.2011.05.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  14 in total

1.  Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Mária Bucová; Daniela Čopíková-Cudráková; Jozef Michalík; Karin Gmitterová; Daniel Čierny; Milan Buc; Vladimíra Ďurmanová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-27       Impact factor: 2.099

Review 2.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 3.  Environmental control of autoimmune inflammation in the central nervous system.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Curr Opin Immunol       Date:  2016-10-04       Impact factor: 7.486

4.  Lack of association between C282Y and H63D polymorphisms in the hemochromatosis gene and risk of multiple sclerosis: A meta-analysis.

Authors:  Nada Starčević Čizmarević; Božena Ćurko-Cofek; Vesna Barac-Latas; Borut Peterlin; Smiljana Ristić
Journal:  Biomed Rep       Date:  2021-12-17

5.  Vitamin D inflammatory cytokines and coronary events: a comprehensive review.

Authors:  Yoav Arnson; Dganit Itzhaky; Morris Mosseri; Vivian Barak; Boaz Tzur; Nancy Agmon-Levin; Howard Amital
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  The initiation and prevention of multiple sclerosis.

Authors:  Alberto Ascherio; Kassandra L Munger; Jan D Lünemann
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

7.  Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy.

Authors:  Amit K Maiti; Swapan K Nath
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

8.  The Impact of Five VDR Polymorphisms on Multiple Sclerosis Risk and Progression: a Case-Control and Genotype-Phenotype Study.

Authors:  Pavel Křenek; Yvonne Benešová; Julie Bienertová-Vašků; Anna Vašků
Journal:  J Mol Neurosci       Date:  2018-03-28       Impact factor: 3.444

9.  CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.

Authors:  Michael P Pender
Journal:  Autoimmune Dis       Date:  2012-01-24

10.  Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Authors:  Jan Dörr; Andrea Döring; Friedemann Paul
Journal:  EPMA J       Date:  2013-01-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.